MoonLake Immunotherapeutics Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent in pure from Q2 2021 to Q3 2025
-
Taxonomy & unit
-
us-gaap: pure
-
Description
-
Percentage of domestic federal statutory tax rate applicable to pretax income (loss).
-
Summary
-
MoonLake Immunotherapeutics quarterly/annual Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent history and growth rate from Q2 2021 to Q3 2025.
- MoonLake Immunotherapeutics Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent for the quarter ending September 30, 2025 was 0 pure, unchanged year-over-year.
- MoonLake Immunotherapeutics annual Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent for 2024 was 0.12 pure, unchanged from 2023.
- MoonLake Immunotherapeutics annual Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent for 2023 was 0.12 pure, unchanged from 2022.
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent, Quarterly (pure)
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent, YoY Quarterly Growth (%)
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent, Annual (pure)
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent, YoY Annual Growth (%)